Holen Sie sich die Stockscreener-App
15.25
17.31%
2.25
Handel nachbörslich:
15.21
-0.04
-0.26%
Schlusskurs vom Vortag:
$13.00
Offen:
$14.31
24-Stunden-Volumen:
7.83M
Relative Volume:
2.81
Marktkapitalisierung:
$1.74B
Einnahmen:
$631.73M
Nettoeinkommen (Verlust:
$-239.78M
KGV:
-7.5495
EPS:
-2.02
Netto-Cashflow:
$-33.45M
1W Leistung:
+11.80%
1M Leistung:
+31.47%
6M Leistung:
+83.51%
1J Leistung:
-5.69%
1-Tages-Spanne:
$13.58
$15.26
1-Wochen-Bereich:
$12.80
$15.26
52-Wochen-Spanne:
$6.78
$17.25
10 X Genomics Inc Stock (TXG) Company Profile
Firmenname
10 X Genomics Inc
Sektor
Branche
Telefon
(925) 401-7300
Adresse
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Vergleichen Sie TXG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TXG
10 X Genomics Inc
|
15.25 | 1.62B | 631.73M | -239.78M | -33.45M | -2.02 |
|
VEEV
Veeva Systems Inc
|
294.86 | 47.73B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
71.56 | 12.83B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
93.71 | 7.99B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
54.29 | 11.72B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
36.22 | 6.85B | 906.14M | -52.62M | 89.62M | -0.3621 |
10 X Genomics Inc Stock (TXG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-11 | Eingeleitet | Piper Sandler | Neutral |
| 2025-02-13 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-09-03 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-22 | Hochstufung | Jefferies | Hold → Buy |
| 2024-07-18 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-07-10 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2024-06-27 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-06-25 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-05-01 | Herabstufung | TD Cowen | Buy → Hold |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-12 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-05-10 | Eingeleitet | Barclays | Overweight |
| 2023-03-31 | Eingeleitet | Stephens | Overweight |
| 2023-02-02 | Eingeleitet | UBS | Neutral |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-08-18 | Herabstufung | Goldman | Neutral → Sell |
| 2022-07-25 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-07-15 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-07-15 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-09-14 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-03-15 | Eingeleitet | William Blair | Outperform |
| 2020-12-02 | Eingeleitet | Goldman | Neutral |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-07-10 | Eingeleitet | Stifel | Buy |
| 2020-03-05 | Eingeleitet | Guggenheim | Buy |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-10-07 | Eingeleitet | BofA/Merrill | Buy |
| 2019-10-07 | Eingeleitet | Cowen | Outperform |
| 2019-10-07 | Eingeleitet | JP Morgan | Overweight |
| 2019-09-24 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
10 X Genomics Inc Aktie (TXG) Neueste Nachrichten
TXG: Canaccord Genuity Raises Price Target for 10x Genomics to $19 | TXG Stock News - GuruFocus
Why 10x Genomics (TXG) Stock Is Trading Up Today - Yahoo Finance
10x Genomics, Inc. SEC 10-Q Report - TradingView
10x Genomics: Q3 Earnings Snapshot - CT Insider
10X Genomics Tops Q3 Estimates And Cuts Losses - Finimize
10x Genomics Inc (TXG) Q3 2025 Earnings Call Highlights: Navigat - GuruFocus
Transcript : 10x Genomics, Inc., Q3 2025 Earnings Call, Nov 06, 2025 - MarketScreener
Is 10x Genomics Inc. (1KJ) stock undervalued historicallyQuarterly Portfolio Report & Proven Capital Preservation Methods - newser.com
10x Genomics (TXG) Reports Q3 Loss, Beats Revenue Estimates - sharewise.com
Compared to Estimates, 10x Genomics (TXG) Q3 Earnings: A Look at Key Metrics - Yahoo Finance
10x Genomics Inc (TXG) Q3 2025 Earnings: EPS of -$0.22 Beats Est - GuruFocus
10x Genomics’s (NASDAQ:TXG) Q3: Strong Sales, Stock Jumps 13.1% - Yahoo Finance
10x Genomics (NASDAQ: TXG) guides fourth‑quarter revenue to $154–$158M after results - Stock Titan
How geopolitical tensions affect 10x Genomics Inc. stockForecast Cut & Daily Profit Focused Screening - newser.com
Can 10x Genomics Inc. stock resist market sell offsQuarterly Earnings Report & Daily Oversold Bounce Ideas - fcp.pa.gov.br
Vanguard Group Inc's Strategic Acquisition of 10x Genomics Inc S - GuruFocus
Advanced analytics toolkit walkthrough for 10x Genomics Inc.2025 Market Outlook & Weekly High Momentum Picks - newser.com
Is 10x Genomics Inc. stock attractive for income investorsMarket Rally & Low Risk Entry Point Tips - fcp.pa.gov.br
Is 10x Genomics Inc. stock a buy before product launchesTrade Risk Summary & Fast Exit and Entry Strategy Plans - newser.com
10x Genomics Earnings: What To Look For From TXG - Yahoo Finance
10X Genomics Hits Day High with 9.65% Surge in Intraday Performance - Markets Mojo
Can a trend reversal in 10x Genomics Inc. lead to recoveryInsider Selling & AI Enhanced Trading Alerts - newser.com
10x Genomics Inc. stock outlook for YEARWeekly Market Summary & Real-Time Buy Signal Alerts - newser.com
Simon Quick Advisors LLC Makes New Investment in 10x Genomics $TXG - MarketBeat
Is 10x Genomics Inc. stock a safe investment in uncertain marketsStop Loss & Daily Entry Point Trade Alerts - newser.com
Is 10x Genomics Inc. stock supported by strong fundamentalsJuly 2025 Reactions & AI Powered Market Entry Ideas - newser.com
Brighton Jones LLC Takes $263,000 Position in 10x Genomics $TXG - MarketBeat
25,103 Shares in 10x Genomics $TXG Purchased by Focus Partners Advisor Solutions LLC - MarketBeat
10x Genomics (NASDAQ:TXG) Shares Up 10%What's Next? - MarketBeat
Sumitomo Mitsui Trust Group, Inc. Adjusts Holdings in 10x Genomi - GuruFocus
Ethic Inc. Invests $289,000 in 10x Genomics $TXG - MarketBeat
10x Genomics (TXG) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance
10x Genomics (TXG) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
10x Genomics Launches the Next Generation of Chromium Flex to Empower Scientists to Massively Scale Single Cell Research - Lelezard
ARK Investment Acquires New Shares in 10x Genomics (TXG) - GuruFocus
10x Genomics Launches New Chromium Flex for Single-Cell Research - Contract Pharma
Why 10x Genomics Inc. stock appeals to dividend seekers2025 Historical Comparison & AI Forecast Swing Trade Picks - fcp.pa.gov.br
Canaccord Genuity Keeps Their Buy Rating on 10x Genomics (TXG) - The Globe and Mail
IQ EQ FUND MANAGEMENT IRELAND Ltd Purchases 184,757 Shares of 10x Genomics $TXG - MarketBeat
Is 10x Genomics Inc. stock ready for a breakoutNew Guidance & Smart Allocation Stock Reports - newser.com
What’s the recovery path for long term holders of 10x Genomics Inc.2025 Risk Factors & AI Based Trade Execution Alerts - newser.com
Is 10x Genomics Inc. stock dividend yield sustainable2025 Risk Factors & AI Powered Market Entry Strategies - newser.com
How 10x Genomics Inc. stock trades before earningsCPI Data & Expert Curated Trade Setups - fcp.pa.gov.br
Sumitomo Mitsui Trust Group Inc. Acquires 654,597 Shares of 10x Genomics $TXG - MarketBeat
10x Genomics (NASDAQ:TXG) Given Average Rating of "Hold" by Brokerages - MarketBeat
Ranking 10x Genomics Inc. among high performing stocks via toolsStop Loss & Fast Momentum Entry Tips - newser.com
Is 10x Genomics Inc. stock entering bullish territoryJuly 2025 Snapshot & Entry and Exit Point Strategies - newser.com
Is 10x Genomics Inc. (1KJ) stock nearing a technical breakoutWeekly Investment Recap & Smart Swing Trading Alerts - newser.com
10x Genomics gets injunction against Parse Biosciences' ATAC Products - MSN
Will 10x Genomics’ (TXG) AI Partnership Shift Its Long-Term Competitive Edge in Genomics? - Yahoo Finance
VIRGINIA RETIREMENT SYSTEMS ET Al Acquires Shares of 54,103 10x Genomics $TXG - MarketBeat
Finanzdaten der 10 X Genomics Inc-Aktie (TXG)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.04%
5.60%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):